Orthofix International (OFIX) Misses Q3 EPS by 36c, reiterates guidance

Orthofix International (NASDAQ: OFIX) reported Q3 EPS of ($0.71), $0.36 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $196.6 million versus the consensus estimate of $196.52 million.

GUIDANCE:

Orthofix International sees FY2024 revenue of $795-800 million, versus the consensus of $797 million. Non-GAAP adjusted EBITDA is expected to range from $64 million to $69 million.
The Company expects to continue to be free cash flow positive for the remainder of 2024.

For earnings history and earnings-related data on Orthofix International (OFIX) click here.

You May Also Be Interested In

• Nucor projects Q3 2026 earnings above prior year, below estimates
• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Sadot Group names Michael Murray as CEO and CFO